Adverum Biotechnologies Inc
NASDAQ:ADVM

Watchlist Manager
Adverum Biotechnologies Inc Logo
Adverum Biotechnologies Inc
NASDAQ:ADVM
Watchlist
Price: 6.04 USD 5.04% Market Closed
Market Cap: 125.6m USD
Have any thoughts about
Adverum Biotechnologies Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Adverum Biotechnologies Inc

Current Assets 161.1m
Cash & Short-Term Investments 153.2m
Other Current Assets 7.8m
Non-Current Assets 73.3m
PP&E 62.9m
Other Non-Current Assets 10.4m
Current Liabilities 27.7m
Accounts Payable 2.1m
Accrued Liabilities 25.5m
Non-Current Liabilities 62.6m
Other Non-Current Liabilities 62.6m

Balance Sheet
Adverum Biotechnologies Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
159
221
222
71
155
66
62
34
68
75
Cash Equivalents
159
221
222
71
155
66
62
34
68
75
Short-Term Investments
0
38
0
120
50
100
367
271
117
22
Total Receivables
0
0
1
0
0
0
0
6
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
1
1
2
3
4
10
5
6
5
6
Total Current Assets
160
261
225
194
209
176
434
317
191
103
PP&E Net
1
3
4
3
4
46
47
119
114
67
PP&E Gross
1
3
4
3
4
46
47
119
114
67
Accumulated Depreciation
0
1
3
5
6
8
10
13
17
15
Intangible Assets
0
0
5
5
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
1
0
0
Other Long-Term Assets
1
0
0
0
1
1
1
3
4
3
Total Assets
162
N/A
264
+63%
235
-11%
202
-14%
213
+6%
223
+4%
483
+117%
440
-9%
308
-30%
173
-44%
Liabilities
Accounts Payable
1
1
1
2
2
4
3
1
2
2
Accrued Liabilities
4
4
6
7
9
15
18
19
30
23
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
1
2
2
2
0
0
0
1
0
0
Total Current Liabilities
5
7
10
11
11
19
21
21
32
25
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
1
1
0
0
0
0
0
0
Other Liabilities
7
5
8
6
2
28
27
102
95
65
Total Liabilities
12
N/A
12
-6%
19
+62%
18
-6%
12
-31%
48
+287%
48
+1%
124
+156%
127
+3%
90
-29%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
37
84
198
254
321
385
503
648
803
920
Additional Paid In Capital
186
337
414
439
523
561
937
965
986
1 004
Other Equity
0
0
0
1
1
1
0
1
2
0
Total Equity
149
N/A
253
+69%
216
-15%
184
-15%
201
+9%
175
-13%
434
+148%
316
-27%
182
-43%
83
-54%
Total Liabilities & Equity
162
N/A
264
+63%
235
-11%
202
-14%
213
+6%
223
+4%
483
+117%
440
-9%
308
-30%
173
-44%
Shares Outstanding
Common Shares Outstanding
2
3
4
5
6
7
10
10
10
10

See Also

Discover More